Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Trends in Cell Biology|March 7, 2021
New Insights into CDK Regulators: Novel Opportunities for Cancer TherapyMarina Bury, Benjamin Le Calvé, Gerardo Ferbeyre, et al.The Biochemical Journal|January 24, 2019
Phosphoglycolate has profound metabolic effects but most likely no role in a metabolic DNA response in cancer cell linesIsabelle Gerin, Marina Bury, Francesca Baldin, et al.Seminars in Cancer Biology|August 28, 2019
Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic processSébastien Marx, Thomas Dal Maso, Jia-Wei Chen, et al.Translational Oncology|April 2, 2013
Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinasesMarina Bury, Anna Andolfi, Bernard Rogister, et al.Cell Reports|November 7, 2019
NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 InhibitorMarina Bury, Benjamin Le Calvé, Frédéric Lessard, et al.The Journal of Biological Chemistry|July 28, 2023
SUZ domain-containing proteins have multiple effects on nonsense-mediated decay target transcriptsMathias Halbout, Marina Bury, Aoife Hanet, et al.International Journal of Oncology|November 27, 2010
Evaluation of the anticancer activities of two fungal polycyclic ethanones, alternethanoxins A and B, and two of their derivativesMarina Bury, Biancavaleria Punzo, Alexander Berestetskiy, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2022
Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metaboliteIsaac P Heremans, Francesco Caligiore, Isabelle Gerin, et al.Journal of Medicinal Chemistry|September 6, 2011
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activityBenjamin Lallemand, Fabien Chaix, Marina Bury, et al.Oncogene|January 29, 2022
Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironmentJames Saliba, Baptiste Coutaud, Kiran Makhani, et al.Pageof 2